APA (7th ed.) Citation

PJ, H., RJ, G., RT, W., W, U., S, D., ME, B., . . . SL, S. (1999). Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17(1), 338. https://doi.org/10.1200/JCO.1999.17.1.338

Chicago Style (17th ed.) Citation

PJ, Hesketh, Gralla RJ, Webb RT, Ueno W, DelPrete S, Bachinsky ME, Dirlam NL, Stack CB, and Silberman SL. "Randomized Phase II Study of the Neurokinin 1 Receptor Antagonist CJ-11,974 in the Control of Cisplatin-induced Emesis." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 17, no. 1 (1999): 338. https://doi.org/10.1200/JCO.1999.17.1.338.

MLA (9th ed.) Citation

PJ, Hesketh, et al. "Randomized Phase II Study of the Neurokinin 1 Receptor Antagonist CJ-11,974 in the Control of Cisplatin-induced Emesis." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 17, no. 1, 1999, p. 338, https://doi.org/10.1200/JCO.1999.17.1.338.